The CRISPR/Cas9 system and immunodeficient NSG mice (Nod/Scid-Il2γ−/−) were combined to mutate the FVIII and FIX genes, generating hemophilia A/B mice with the NSG background (HemoA/B-NSG mice). The gene discussed is F9; the disease is hemophilia.